DCO:NYSEDucommun Incorporated Analysis
Data as of 2026-08-10 - not real-time
$197.07
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At $197.07, Ducommun Incorporated shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 15.6% over the past 30 days. Momentum indicators put RSI at 64.0 (approaching overbought) with MACD reading bullish. The recent range runs from support at $161.87 up to resistance at $210.39.
On valuation the read is overvalued — earnings multiple of 37.0 versus a 30.7 sector average, above the peer group. Revenue is growing at 11.8% on a -2.5% profit margin.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 51.9%, a beta of 1.41 and a maximum drawdown of 16.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 2 out of 10.
On valuation the read is overvalued — earnings multiple of 37.0 versus a 30.7 sector average, above the peer group. Revenue is growing at 11.8% on a -2.5% profit margin.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 51.9%, a beta of 1.41 and a maximum drawdown of 16.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 2 out of 10.
Top Market Events
COSTA MESA, Calif., July 23, 2026 GLOBE NEWSWIRE -- Ducommun Incorporated NYSE: DCO “Ducommun” or the “Company”...COSTA MESA, Calif., Aug. 06, 2026 GLOBE NEWSWIRE -- Ducommun Incorporated NYSE: DCO “Ducommun” or the “Company”...Ducommun Incorporated NYSE:DCO is among the 8 Best Mid Cap Defense Stocks to Buy, with 18 hedge funds having a stake in...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 129.80
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 37.0 versus sector average of 30.7
- Trading above the 200-day average of 129.80
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 37.0 versus sector average of 30.7
- Negative profit margin of -2.5%
- Negative return on equity of -3.0%
Key Metrics & Analysis
Financial Health
Revenue Growth11.80%
Profit Margin-2.45%
P/E Ratio37.0
ROE-3.03%
ROA4.97%
Debt/Equity48.49
P/B Ratio4.3
Op. Cash Flow$-11800000
Free Cash Flow$57.5M
Industry P/E30.7
Technical Analysis
TrendBullish
RSI64.0
Support$161.87
Resistance$210.39
MA 20$178.67
MA 50$170.67
MA 200$129.80
MACDBullish
VolumeDecreasing
Fear & Greed Index93.84
Valuation
Fair Value$60.58
Target Price$197.80
Upside/Downside0.37%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.41
Volatility51.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.